Target intelligence / Profile preview

SMG1 pseudogene 3 (SMG1P3)

Target
SMG1P3
Molecular classification
Pseudogene
01

Overview

SMG1 pseudogene 3 (SMG1P3) is a processed pseudogene related to the SMG1 gene, which encodes a serine/threonine-protein kinase involved in nonsense-mediated mRNA decay (NMD)[3][7]. SMG1P3 itself is not transcribed into a functional protein product and thus is not considered functionally active in biological processes. It is sometimes referenced in genomic annotation due to sequence similarity to the functional SMG1 gene, but it does not play a role in therapeutic targeting, disease biology, or molecular function in cells[3][7][8]. SMG1P3 should not be confused with SMG1, which is a functional kinase involved in the NMD pathway and DNA damage response, and is investigated as a potential therapeutic target in some contexts. The designation "pseudogene" in SMG1P3 means it lacks protein-coding capacity and functional activity[7][3][8].

Other names
SMG1P3, nonsense mediated mRNA decay associated PI3K related kinase pseudogene 3smg-1 homolog, phosphatidylinositol 3-kinase-related kinase pseudogeneSMG1P3
02

Mechanism of action

Not applicable; no mechanism due to pseudogene status

03

Biological functions

No known biological function — classified as a pseudogene and not expressed as a functional protein
04

Disease associations

None directly attributed; not described in disease mechanisms due to pseudogene status
05

Safety considerations

None; not a therapeutic target.
06

Interacting drugs

None; SMG1P3 does not encode a protein and thus has no known drug interactions
07

Biomarkers

None established for patient selection or efficacy

Beyond the preview

Go deeper on SMG1 pseudogene 3 (SMG1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMG1 pseudogene 3 (SMG1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call